Arun V Ravindran1, Lynda G Balneaves2, Guy Faulkner3, Abigail Ortiz4, Diane McIntosh5, Rachel L Morehouse6, Lakshmi Ravindran2, Lakshmi N Yatham5, Sidney H Kennedy2, Raymond W Lam5, Glenda M MacQueen7, Roumen V Milev8, Sagar V Parikh9. 1. Department of Psychiatry, University of Toronto, Toronto, Ontario arun.ravindran@camh.ca. 2. Department of Psychiatry, University of Toronto, Toronto, Ontario. 3. School of Kinesiology, University of British Columbia, Vancouver, British Columbia. 4. Department of Psychiatry, University of Ottawa, Ottawa, Ontario. 5. Department of Psychiatry, University of British Columbia, Vancouver, British Columbia. 6. Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia. 7. Department of Psychiatry, University of Calgary, Calgary, Alberta. 8. Department of Psychiatry, Queen's University, Kingston, Ontario. 9. Department of Psychiatry, University of Toronto, Toronto, Ontario Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
Abstract
BACKGROUND: The Canadian Network for Mood and Anxiety Treatments (CANMAT) conducted a revision of the 2009 guidelines by updating the evidence and recommendations. The scope of the 2016 guidelines remains the management of major depressive disorder (MDD) in adults, with a target audience of psychiatrists and other mental health professionals. METHODS: Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. "Complementary and Alternative Medicine Treatments" is the fifth of six sections of the 2016 guidelines. RESULTS: Evidence-informed responses were developed for 12 questions for 2 broad categories of complementary and alternative medicine (CAM) interventions: 1) physical and meditative treatments (light therapy, sleep deprivation, exercise, yoga, and acupuncture) and 2) natural health products (St. John's wort, omega-3 fatty acids; S-adenosyl-L-methionine [SAM-e], dehydroepiandrosterone, folate, Crocus sativus, and others). Recommendations were based on available data on efficacy, tolerability, and safety. CONCLUSIONS: For MDD of mild to moderate severity, exercise, light therapy, St. John's wort, omega-3 fatty acids, SAM-e, and yoga are recommended as first- or second-line treatments. Adjunctive exercise and adjunctive St. John's wort are second-line recommendations for moderate to severe MDD. Other physical treatments and natural health products have less evidence but may be considered as third-line treatments. CAM treatments are generally well tolerated. Caveats include methodological limitations of studies and paucity of data on long-term outcomes and drug interactions.
BACKGROUND: The Canadian Network for Mood and Anxiety Treatments (CANMAT) conducted a revision of the 2009 guidelines by updating the evidence and recommendations. The scope of the 2016 guidelines remains the management of major depressive disorder (MDD) in adults, with a target audience of psychiatrists and other mental health professionals. METHODS: Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. "Complementary and Alternative Medicine Treatments" is the fifth of six sections of the 2016 guidelines. RESULTS: Evidence-informed responses were developed for 12 questions for 2 broad categories of complementary and alternative medicine (CAM) interventions: 1) physical and meditative treatments (light therapy, sleep deprivation, exercise, yoga, and acupuncture) and 2) natural health products (St. John's wort, omega-3 fatty acids; S-adenosyl-L-methionine [SAM-e], dehydroepiandrosterone, folate, Crocus sativus, and others). Recommendations were based on available data on efficacy, tolerability, and safety. CONCLUSIONS: For MDD of mild to moderate severity, exercise, light therapy, St. John's wort, omega-3 fatty acids, SAM-e, and yoga are recommended as first- or second-line treatments. Adjunctive exercise and adjunctive St. John's wort are second-line recommendations for moderate to severe MDD. Other physical treatments and natural health products have less evidence but may be considered as third-line treatments. CAM treatments are generally well tolerated. Caveats include methodological limitations of studies and paucity of data on long-term outcomes and drug interactions.
Keywords:
clinical practice guidelines; complementary and alternative medicine; evidence-based medicine; exercise; light therapy; major depressive disorder; meta-analysis; natural health products; sleep deprivation; systematic reviews
Authors: Kelly J Rohan; Jennifer N Mahon; Maggie Evans; Sheau-Yan Ho; Jonah Meyerhoff; Teodor T Postolache; Pamela M Vacek Journal: Am J Psychiatry Date: 2015-04-10 Impact factor: 18.112
Authors: Marlene P Freeman; Maurizio Fava; James Lake; Madhukar H Trivedi; Katherine L Wisner; David Mischoulon Journal: J Clin Psychiatry Date: 2010-06 Impact factor: 4.384
Authors: Amanda T Woodward; Kai M Bullard; Robert J Taylor; Linda M Chatters; Raymond E Baser; Brian E Perron; James S Jackson Journal: Psychiatr Serv Date: 2009-10 Impact factor: 3.084
Authors: Charles H Bombardier; Casey B Azuero; Jesse R Fann; Donald D Kautz; J Scott Richards; Sunil Sabharwal Journal: Top Spinal Cord Inj Rehabil Date: 2021
Authors: Emma Morton; Erin E Michalak; Anthony Levitt; Robert D Levitan; Amy Cheung; Rachel Morehouse; Rajamannar Ramasubbu; Lakshmi N Yatham; Edwin M Tam; Raymond W Lam Journal: Can J Psychiatry Date: 2020-06-23 Impact factor: 4.356
Authors: Shan Xing; Gregory S Calip; Alex D Leow; Shiyun Kim; Glen T Schumock; Daniel R Touchette; Todd A Lee Journal: J Diabetes Complications Date: 2017-12-27 Impact factor: 2.852
Authors: Raymond W Lam; Minnie Y Teng; Young-Eun Jung; Vanessa C Evans; John F Gottlieb; Trisha Chakrabarty; Erin E Michalak; Jill K Murphy; Lakshmi N Yatham; Dorothy K Sit Journal: Can J Psychiatry Date: 2019-12-12 Impact factor: 4.356
Authors: Jerome Sarris; Wolfgang Marx; Melanie M Ashton; Chee H Ng; Nicole Galvao-Coelho; Zahra Ayati; Zhang-Jin Zhang; Siegfried Kasper; Arun Ravindran; Brian H Harvey; Adrian Lopresti; David Mischoulon; Jay Amsterdam; Lakshmi N Yatham; Michael Berk Journal: Can J Psychiatry Date: 2021-02-18 Impact factor: 4.356